Study characteristics and quality assessment
Table 1 lists detailed information from the 5 included studies. The
included studies were published between 2014 and 2019. The number of
participants per study ranged from 22 to 90, with a total number of
228. Patients have received
fingolimod were recorded in 114 of 228 (50%). All studies were
randomized controlled trials.
Table 1 Clinical and demographic characteristics of 228
patients from 5 studies included in the systematic review